What is PacificHealth Laboratories, Inc. (PHLI) stock price today?

PacificHealth Laboratories, Inc. (PHLI) is currently trading at $0.00.

What is PHLI P/E ratio?

PacificHealth Laboratories, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is PHLI return on equity (ROE)?

PacificHealth Laboratories, Inc.'s return on equity (ROE) is 0.00%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is PacificHealth Laboratories, Inc.'s market cap?

PacificHealth Laboratories, Inc. has a market capitalization of $438307.

OTC · Household & Personal Products

PacificHealth Laboratories, Inc. (PHLI) Stock

$0.00 OTC: PHLI Consumer Defensive

Valuation

Metric	Value
Price	$0.00
Market Cap	$438307
P/E Ratio	0.00
P/B Ratio	0.44
P/S Ratio	0.06
EPS (TTM)	$-0.02
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	0.00%
ROA	-25.72%
ROCE	-38.53%
Gross Margin	0.00%
Operating Margin	-6.86%
Net Margin	-7.03%
Debt/Equity	0.00
Current Ratio	2.00

Annual Financials (USD)

Metric	2007	2008	2009	2010	2011
Revenue	$7.0M	$7.0M	$8.0M	$7.0M	$7.0M
Operating Profit	$-1.0M	$-2.0M	$-2.0M	$-1.0M	$0
Net Profit	$-1.0M	$-2.0M	$-2.0M	$-1.0M	$0
EPS	$-0.10	$-0.15	$-0.11	$-0.05	$-0.02
Op Margin	-18.3%	-28.2%	-24.3%	-10.6%	-6.9%

Balance Sheet (USD)

Metric	2007	2008	2009	2010	2011
Total Assets	$5.0M	$3.0M	$3.0M	$1.0M	$2.0M
Total Liabilities	$1.0M	$1.0M	$1.0M	$1.0M	$1.0M
Cash	$2.0M	$1.0M	$0	$0	$1.0M
Borrowings	$0	$0	$0	$0	$0

Latest News

RODEO AT THE RACETRACK AND SAM HOUSTON ANNOUNCE PARTNERSHIP TO BRING PRCA RODEO EXPERIENCE TO HOUSTON PR Newswire · Jul 28, 2026 Many feared trapped in quake-hit Japan mall AFP · Jul 28, 2026 Female athletes surge in NIL deals as Learfield reports a 123% jump in participation Associated Press · Jul 28, 2026 ‘The Madness Pill’ Review: Delusion’s Chemical Source The Wall Street Journal · Jul 28, 2026 IQVIA Holdings Inc. Q2 2026 Earnings Call Summary Moby · Jul 28, 2026

Cash Flow (USD)

Metric	2007	2008	2009	2010	2011
Operating Cash Flow	$-1.0M	$-1.0M	$-1.0M	$0	$-1.0M
Investing Cash Flow	$0	$-1.0M	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$-1.0M	$-1.0M	$-1.0M	$0	$1.0M
Free Cash Flow	$-2.0M	$-1.0M	$-1.0M	$0	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	0.58
FCF Yield	-118.59%
Quick Ratio	1.94
Interest Coverage	-32.27
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BGACFBioNeutra Global Corporation	$0.01	+0.00%	-0.16	$260113	0.00%
FLAFFarm Lands of Africa, Inc.	$0.00	—	0.00	$460417	0.00%
HUMBFHumble & Fume Inc.	$0.00	—	-0.03	$521590	0.00%
MEALFNabati Foods Global Inc.	$0.01	+0.00%	-0.21	$435831	0.00%
PECDPet Ecology Brands, Inc.	$0.01	+0.00%	—	$406648	0.00%

About PacificHealth Laboratories, Inc.

PacificHealth Laboratories, Inc. (PHLI) specializes in developing and marketing nutritional products designed to boost overall health and enhance athletic performance for consumers both within the United States and internationally. The company's offerings predominantly target key aspects of athletic performance, such as optimal sports performance, proper hydration, sustained energy (fueling), and efficient muscle recovery. PHLI's product line includes notable items like ENDUROX R4, a drink formulated for muscle recovery; ACCELERADE, a protein-powered sports beverage; energy gels such as ACCEL GEL and 2ND SURGE; the exercise supplement ENDUROX EXCEL; and Body Glove Surge. Additionally, they provide ACCELERADE HYDRO, a specific formulation for less intense workouts, which supports hydration, energy, and recovery before, during, and after physical activity. Reaching consumers through diverse distribution channels, PHLI's products are available in sports specialty and natural product retailers and chains, as well as directly through their official website. PacificHealth Laboratories, Inc. was founded in 1995 and is headquartered in Matawan, New Jersey.

PacificHealth Laboratories, Inc. (PHLI) stock trades at $0.00 with a market capitalization of $438307. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.44, price-to-sales of 0.06. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, PacificHealth Laboratories, Inc. generates a return on equity (ROE) of 0.00%, return on capital employed of -38.53%, an operating margin of -6.86%, a net profit margin of -7.03%.

Official website: www.pacifichealthlabs.com